ORIGINAL RESEARCH article
Front. Endocrinol.
Sec. Reproduction
Volume 16 - 2025 | doi: 10.3389/fendo.2025.1547550
This article is part of the Research TopicEndocrine Regulation of Ovarian Follicle Development and Oocyte Maturation: Molecular Mechanisms and Functional InsightsView all articles
Non-targeted metabolomic analysis of follicular fluid in infertile individuals with poor ovarian response
Provisionally accepted- 1Nanjing Medical University, Nanjing, China
- 2Reproductive Medicine Center, Changzhou Maternal and Child Health Care Hospital, Changzhou, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Background: Poor ovarian response (POR) is a pathological condition characterized by inadequate ovarian response to gonadotropin stimulation in patients undergoing in vitro fertilization and embryo transfer. It represents a primary cause of failure in many assisted reproductive technology treatments.Utilizing non-targeted metabolomics technology applied to follicular fluid, this research aims to elucidate the metabolic characteristics associated with POR, explore the underlying molecular mechanisms, and identify potential biomarkers. By analyzing metabolic factors that influence oocyte quality, we aspire to provide insights for the early detection and intervention of patients with POR.In this research, 60 follicular fluid samples were collected for a non-targeted metabolomic study, including 30 samples from POR patients and 30 from women with normal ovarian reserve.The orthogonal partial least squares discriminant analysis model was employed to discern separation trends between the two groups. Pathway enrichment analysis was performed using the Kyoto metabonomic 删除[名悠緑香]: 4663 删除[名悠緑香]: metabonomic 删除[名悠緑香]: Encyclopedia of Genes and Genomes (KEGG) database. Additionally, random forest and logistic regression models were utilized to identify biomarkers indicative of POR within the follicular fluid.Results: Based on data from the Human Metabolome Database, our metabolomic analysis identified 40 differential metabolites associated with POR, including 18 up-regulated and 22 down-regulated metabolites. KEGG pathway analysis revealed that these metabolites predominantly participate in glycerophospholipid metabolism, choline metabolism in cancer, autophagy processes. Notably, perillyl aldehyde emerged as a potential biomarker for POR.This study represents the first comprehensive examination of metabolic alterations in follicular fluid among patients with POR using non-targeted metabolomics technology. We have identified significant metabolic changes within the follicular fluid of individuals affected by POR which may offer valuable insights into therapeutic strategies for managing this condition as well as improving outcomes in assisted reproductive technologies.
Keywords: nontargeted metabolomics, Poor ovarian response, Follicular Fluid, Oocytes, Metabolomics
Received: 18 Dec 2024; Accepted: 15 Apr 2025.
Copyright: © 2025 Guo, Song, Xia, Jiang, Yang, Wei, Chen and Xue. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Chen Wei, Nanjing Medical University, Nanjing, China
Li Chen, Nanjing Medical University, Nanjing, China
Pingping Xue, Nanjing Medical University, Nanjing, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.